137 related articles for article (PubMed ID: 38345168)
21. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis.
Jin J; Liu H; Jin M; Li W; Xu H; Wei F
Aging (Albany NY); 2020 Jun; 12(12):11623-11635. PubMed ID: 32554866
[TBL] [Abstract][Full Text] [Related]
22. Circ_0001178 regulates miR-382/VEGFA axis to facilitate hepatocellular carcinoma progression.
Gao S; Hu W; Huang X; Huang X; Chen W; Hao L; Chen Z; Wang J; Wei H
Cell Signal; 2020 Aug; 72():109621. PubMed ID: 32240747
[TBL] [Abstract][Full Text] [Related]
23. Exosomal hsa_circ_0004658 derived from RBPJ overexpressed-macrophages inhibits hepatocellular carcinoma progression via miR-499b-5p/JAM3.
Zhang L; Zhang J; Li P; Li T; Zhou Z; Wu H
Cell Death Dis; 2022 Jan; 13(1):32. PubMed ID: 35013102
[TBL] [Abstract][Full Text] [Related]
24. Circular RNA circ-102,166 acts as a sponge of miR-182 and miR-184 to suppress hepatocellular carcinoma proliferation and invasion.
Li R; Deng Y; Liang J; Hu Z; Li X; Liu H; Wang G; Fu B; Zhang T; Zhang Q; Yang Y; Chen G; Liu W
Cell Oncol (Dordr); 2021 Apr; 44(2):279-295. PubMed ID: 33034848
[TBL] [Abstract][Full Text] [Related]
25. circ_0001588 Induces the Malignant Progression of Hepatocellular Carcinoma by Modulating miR-874/CDK4 Signaling.
Bin X; Chen Y; Ma J; Tang R; Zhao Z; Wang K; Wang J
J Immunol Res; 2021; 2021():3759879. PubMed ID: 34722778
[TBL] [Abstract][Full Text] [Related]
26. Hsa_circ_0101432 promotes the development of hepatocellular carcinoma (HCC) by adsorbing miR-1258 and miR-622.
Zou H; Xu X; Luo L; Zhang Y; Luo L; Yao Y; Xiang G; Huang X; Wang G
Cell Cycle; 2019 Oct; 18(19):2398-2413. PubMed ID: 31095447
[TBL] [Abstract][Full Text] [Related]
27. Aloin decelerates the progression of hepatocellular carcinoma through circ_0011385/miR-149-5p/WT1 axis.
Fu D; Ji Q; Wang C; Yu L; Yu R
Cell Cycle; 2021 Dec; 20(23):2476-2493. PubMed ID: 34720052
[TBL] [Abstract][Full Text] [Related]
28. Hsa_circ_0003945 promotes progression of hepatocellular carcinoma by mediating miR-34c-5p/LGR4/β-catenin axis activity.
Lyu LH; Zhang CY; Yang WJ; Jin AL; Zhu J; Wang H; Liu T; Wang BL; Cheng JW; Yang XR; Guo W
J Cell Mol Med; 2022 Apr; 26(8):2218-2229. PubMed ID: 35170199
[TBL] [Abstract][Full Text] [Related]
29. Circular RNA circ_0001459 accelerates hepatocellular carcinoma progression via the miR-6165/IGF1R axis.
Shen D; Zhao H; Zeng P; Ge M; Shrestha S; Zhao W
Ann N Y Acad Sci; 2022 Jun; 1512(1):46-60. PubMed ID: 35199365
[TBL] [Abstract][Full Text] [Related]
30. Circ_0091581 Promotes the Progression of Hepatocellular Carcinoma Through Targeting miR-591/FOSL2 Axis.
Ji C; Hong X; Lan B; Lin Y; He Y; Chen J; Liu X; Ye W; Mo Z; She Z; Lin S
Dig Dis Sci; 2021 Sep; 66(9):3074-3085. PubMed ID: 33040214
[TBL] [Abstract][Full Text] [Related]
31. Circular RNA-ABCB10 suppresses hepatocellular carcinoma progression through upregulating NRP1/ABL2 via sponging miR-340-5p/miR-452-5p.
Yang W; Ju HY; Tian XF
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2347-2357. PubMed ID: 32196586
[TBL] [Abstract][Full Text] [Related]
32. Circular RNA hsa_circ_101555 promotes hepatocellular carcinoma cell proliferation and migration by sponging miR-145-5p and regulating CDCA3 expression.
Gu X; Zhang J; Ran Y; Pan H; Jia J; Zhao Y; Zhao X; Li W; Song S; Yu X
Cell Death Dis; 2021 Apr; 12(4):356. PubMed ID: 33824281
[TBL] [Abstract][Full Text] [Related]
33. Circ-EIF3I Promotes Hepatocellular Carcinoma Progression Through Modulating miR-361-3p/DUSP2 Axis.
Ni L; Gao Q; Zhao Q; Dai K; Jin M; Fu C; Xiao M; Zhu W; Bi Y
DNA Cell Biol; 2024 May; 43(5):258-266. PubMed ID: 38513057
[TBL] [Abstract][Full Text] [Related]
34. circRNA 001306 enhances hepatocellular carcinoma growth by up-regulating CDK16 expression via sponging miR-584-5p.
Liu Q; Wang C; Jiang Z; Li S; Li F; Tan HB; Yue SY
J Cell Mol Med; 2020 Dec; 24(24):14306-14315. PubMed ID: 33135290
[TBL] [Abstract][Full Text] [Related]
35. Circ_0064288 acts as an oncogene of hepatocellular carcinoma cells by inhibiting miR-335-5p expression and promoting ROCK1 expression.
Nie Y; Zhu X; Bu N; Jiang Y; Su Y; Pan K; Li S
BMC Cancer; 2022 Mar; 22(1):265. PubMed ID: 35287604
[TBL] [Abstract][Full Text] [Related]
36. Circ_0003998 enhances doxorubicin resistance in hepatocellular carcinoma by regulating miR-218-5p/EIF5A2 pathway.
Li X; He J; Ren X; Zhao H; Zhao H
Diagn Pathol; 2020 Dec; 15(1):141. PubMed ID: 33308276
[TBL] [Abstract][Full Text] [Related]
37. Circ_0091579 exerts an oncogenic role in hepatocellular carcinoma via mediating miR-136-5p/TRIM27.
Mao Y; Ding Z; Jiang M; Yuan B; Zhang Y; Zhang X
Biomed J; 2022 Dec; 45(6):883-895. PubMed ID: 34974169
[TBL] [Abstract][Full Text] [Related]
38. Circ_0001955 facilitates hepatocellular carcinoma (HCC) tumorigenesis by sponging miR-516a-5p to release TRAF6 and MAPK11.
Yao Z; Xu R; Yuan L; Xu M; Zhuang H; Li Y; Zhang Y; Lin N
Cell Death Dis; 2019 Dec; 10(12):945. PubMed ID: 31822654
[TBL] [Abstract][Full Text] [Related]
39. Circ_0027089 regulates NACC1 by targeting miR-136-5p to aggravate the development of hepatitis B virus-related hepatocellular carcinoma.
He W; Zhu X; Tang X; Xiang X; Yu J; Sun H
Anticancer Drugs; 2022 Jan; 33(1):e336-e348. PubMed ID: 34419960
[TBL] [Abstract][Full Text] [Related]
40. Circ_0008305-mediated miR-660/BAG5 axis contributes to hepatocellular carcinoma tumorigenesis.
Yan F; Fan B; Wang J; Wei W; Tang Q; Lu L; Luo Z; Pu J; Yang SS
Cancer Med; 2021 Feb; 10(3):833-842. PubMed ID: 33481351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
